Lannett

Lannett Company, Inc., established in 1942, is a U.S.-based pharmaceutical company specializing in the development, manufacturing, and distribution of unique pharmaceutical products, including generic drugs and authorized generic versions. Operating within the Healthcare and Pharmaceuticals sectors, Lannett has built a strong reputation for producing high-quality medications that improve and save lives. The company utilizes state-of-the-art facilities for research and development, manufacturing, packaging, and distribution, ensuring rigorous adherence to safety, quality, and efficacy standards across its operations.

With 7 locations and an employee range of 1,000 - 5,000 employees, Lannett manages a complex pharmaceutical supply chain. This operational scale is supported by a dedicated workforce focused on efficiency and meeting market demands. The company's commitment to its mission is driven by its personnel, whose expertise is vital in navigating the pharmaceutical landscape. To learn more about the individuals contributing to Lannett's success and operational strategies, explore Meet Lannett's team.

Lannett reported a revenue of $371.3M, underscoring its significant market presence. The company's core offerings include generic pharmaceuticals, addressing various therapeutic areas and contributing to healthcare accessibility. Its competitive positioning is shaped by its ability to produce cost-effective alternatives to branded drugs. Further details on its financial performance are available via Explore financial highlights. Lannett's strategic focus on generic drug development and manufacturing solidifies its role in the broader healthcare ecosystem, providing essential treatments to a wide patient base.